Tag archive for ‘Professor Omar Khan’

FDA Approves Teva’s New Formulation For Longer-lasting Copaxone

– – U.S. Food and Drug Administration (FDA) has approved Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) new dose of COPAXONE drug application (sNDA) for three-times-a-week  40mg/mL. This new More...

Wordpress site Developed by Fixing WordPress Problems